TRIL Activators encompass a unique class of chemicals that act to enhance the functional activity of TRIL, a protein integral to specific cellular signaling pathways. These activators function by engaging with various molecular mechanisms, each tailored to amplify the activity of TRIL through distinct yet converging pathways. For example, an activator might increase the concentration of secondary messengers within the cell, such as cAMP, which in turn can initiate a signaling cascade that results in the phosphorylation of proteins associated with the same pathway as TRIL. This post-translational modification can directly enhance TRIL's activity by changing its conformation, thereby increasing its ability to interact with partner molecules. Another activator could bind to a regulatory domain of TRIL, thereby stabilizing the protein in its active form. Some activators might also act on the membrane lipid composition, altering the microenvironment of TRIL and promoting its interaction with essential cofactors, thereby enhancing the protein's functional capacity.
Each TRIL activator, while distinct in its chemical structure, is designed to target specific aspects of the protein's regulatory mechanism. For instance, certain activators may mimic ligands that bind to TRIL, leading to an allosteric change that favors its active state, while others could inhibit phosphatases that typically downregulate TRIL activity, thereby sustaining its action over a longer duration. These activators may also influence the expression of scaffolding proteins that interact with TRIL, facilitating a more robust assembly of signaling complexes where TRIL serves a pivotal role. By augmenting the protein-protein interactions and enhancing the stability of these complexes, the activators ensure that TRIL's activity is maintained at an elevated level. The combined actions of these compounds result in a fine-tuned enhancement of TRIL's activity, enabling the protein to fulfill its role more efficiently within the cellular context it operates. Each activator's mechanism is precisely attuned to the intricacies of TRIL's function, ensuring that the activation is not merely a general increase in activity but a targeted enhancement of TRIL's specific role within the cell.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to an increase in cAMP levels. Elevated cAMP activates PKA, which can then phosphorylate various substrates, including proteins that interact with TRIL, enhancing its signaling capabilities. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). PKC activation can lead to phosphorylation of proteins that associate with TRIL, ultimately increasing TRIL-mediated signaling. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration, which can stimulate calcium-dependent kinases that enhance TRIL signaling pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) activates S1P receptors, which can trigger downstream signaling cascades that potentiate TRIL's functional activity in immune signaling. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, similar to Ionomycin, and enhances intracellular calcium levels, thus promoting activation of calcium-dependent pathways that can amplify TRIL signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAPK, which can shift signaling dynamics to favor TRIL activation by reducing competitive signaling through the p38 pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can indirectly enhance TRIL activity by modulating the PI3K/Akt pathway, thereby influencing pathways that converge on TRIL signaling. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that inhibits certain kinases, leading to the enhancement of TRIL signaling by reducing inhibitory phosphorylations on associated pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that might enhance TRIL signaling by reducing competitive phosphorylation events, allowing TRIL-associated pathways to become more active. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased intracellular calcium levels that stimulate TRIL through calcium-dependent signaling mechanisms. | ||||||